BRIEF published on 10/21/2024 at 20:05, 1 year 10 months ago ABIONYX Pharma receives positive EMA opinion for CER-001 ABIONYX Pharma CER-001 EMA AMM LCAT Deficiency
PRESS RELEASE published on 10/21/2024 at 20:00, 1 year 10 months ago Inside Information / Other news releases ABIONYX Pharma receives positive feedback from EMA for CER-001 in LCAT Deficiency, allowing submission of data from 2 prospective process validation batches for MAA manufacturing ABIONYX Pharma CER-001 EMA LCAT Deficiency Process Validation Batches
BRIEF published on 08/22/2024 at 18:05, 2 years ago ABIONYX Pharma: Review of the first half of 2024 Biotechnology Fundraising Treasury Turnover ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 2 years ago Inside Information / Other news releases ABIONYX Pharma reports €2.4m sales and €5.3m cash position for H1 2024, focused on innovative therapies. Raised €3.4m for sepsis program in the US Sales Cash Position Innovative Therapies ABIONYX Pharma Sepsis
BRIEF published on 07/01/2024 at 09:27, 2 years 1 month ago ABIONYX Successfully Completes €3.4 Million Capital Increase Capital Increase Biotech Shares And Warrants ABIONYX Sepsis Development
PRESS RELEASE published on 07/01/2024 at 09:22, 2 years 1 month ago Inside Information / Other news releases ABIONYX successfully completes a capital increase of c.€3.4 million through the issuance of shares with warrants. The fundraising aims to strengthen the company's cash position for its development in sepsis and the United States Fundraising Capital Increase Sepsis ABIONYX Shares With Warrants
BRIEF published on 06/27/2024 at 19:27, 2 years 1 month ago ABIONYX Pharma Achieves Unanimous Approval at Combined General Meeting Shareholders Biotech General Meeting Resolutions ABIONYX Pharma
PRESS RELEASE published on 06/27/2024 at 19:22, 2 years 1 month ago Inside Information / Other news releases ABIONYX Pharma announces unanimous approval of all resolutions at its Combined General Meeting. Shareholders renew mandates and approve buyback program Shareholders Buyback Program Renewal Combined General Meeting ABIONYX Pharma
BRIEF published on 06/19/2024 at 21:20, 2 years 2 months ago ABIONYX announces a capital increase without preferential subscription rights Biotechnology Actions United States Increase In Capital Sepsis
PRESS RELEASE published on 06/19/2024 at 21:15, 2 years 2 months ago Inside Information / Other news releases ABIONYX announces capital increase of c.€3.4 million with share issuance and warrants, strengthening financial position for Sepsis and US development, supported by ORSAY 53 investment company Capital Increase Share Issuance ABIONYX Sepsis Development ORSAY 53
Published on 08/22/2026 at 05:50, 1 day 17 hours ago Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 1 day 18 hours ago Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 1 day 23 hours ago BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 2 days ago Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/21/2026 at 23:00, 2 days ago Silver Storm Announces $7.5 Million Non-Brokered Private Placement with Eric Sprott
Published on 08/21/2026 at 19:36, 2 days 3 hours ago EQS-Adhoc: KAP AG ANNOUNCES CHANGE IN SHAREHOLDER STRUCTURE
Published on 08/21/2026 at 19:11, 2 days 4 hours ago EQS-Adhoc: Marley Spoon Group SE: Discussions with Misfits Market as permanent US fulfillment agent
Published on 08/21/2026 at 18:14, 2 days 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/21/2026 at 17:27, 2 days 6 hours ago EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Published on 08/21/2026 at 16:30, 2 days 7 hours ago BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades
Published on 08/18/2026 at 11:15, 5 days 12 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 6 days 3 hours ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 6 days 15 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
